Dassault Aviation (AM.PA) — Investment Thesis #

Date: 2026-05-14 Price: EUR 283.80 | Forward P/E: 17.7x | Graham Score: 4/7 | Sector: Aerospace & Defense (France)

Hypothesis #

Dassault Aviation trades for EUR 283.80 while its identifiable assets per share total EUR 277.53 — EUR 118.54 of net cash plus EUR 158.99 of Thales equity stake (27% of HO.PA at current EUR 222.7). This means the entire operating Falcon + Rafale manufacturing franchise is being valued at EUR 6.27 per share — essentially free.

This is a structural sum-of-parts mispricing, not a momentum trade. The market is so focused on Falcon business jet cyclicality and FCAS political risk that it's ignoring the 220-aircraft Rafale backlog (175 export + 45 France), the EUR 46.6B total backlog providing 5+ years revenue visibility, and the Thales stake that has compounded at high-teens annually.

The core mispricing: you are buying the Falcon + Rafale operating business at ~1x annual operating earnings, with EUR 9.2B of net cash as a built-in margin of safety, and a 27% Thales stake as embedded growth optionality.

What Changed (Why Now) #

Three things converged in May 2026:

1. The European defense sector pulled back 9-12% in March-May 2026 on ceasefire speculation and valuation reset (MSCI Europe Aerospace & Defence Index -9.2% in March, its worst month in five years). Rheinmetall fell 9% in one session on JPMorgan downgrade. Dassault was dragged with the sector despite no company-specific bad news — it's now -21.6% from its EUR 361.80 peak.

2. Ex-dividend date tomorrow (2026-05-15) for EUR 4.78 per share — +42% YoY. Buying today captures the dividend. The board grew the dividend from EUR 3.37 to EUR 4.78 (35% payout ratio on adjusted EUR 13.60 EPS), signaling confidence in cash generation. France's new 2026 withholding tax rules dropped non-resident WHT from 25% to 12.8%.

3. MRFA India catalyst is real but stuck on source-code dispute. India's DAC issued Acceptance of Necessity for 114 Rafale on 2026-02-12. CEO Trappier publicly targets 2026 signing. The current stall (France refusing source-code access) is a negotiation, not a rejection. If signed, ~EUR 11B+ contract = 25% addition to current backlog in one transaction — material re-rating event.

Why the SOTP Is the Core Argument #

Most valuations of Dassault start from earnings. That's the wrong place. Here's the asset breakdown:

Against operating net income of approximately EUR 443-527M (FY2025 net income EUR 1,061M minus Thales equity contribution EUR 534M = EUR 527M pure operating), the implied operating P/E is 0.9-1.1x. The Rafale + Falcon manufacturing business — one of the world's premier defense aerospace franchises — is being priced as if it earns zero.

This is the asymmetry. If the operating business is worth even 8x earnings (the low end for a cyclical industrial), the SOTP fair value is EUR 277 + (EUR 6.50 × 8) = EUR 329, implying +16% upside. At 12x earnings (more consistent with defense peer multiples), fair value rises to EUR 355, matching analyst consensus.

Framework Reasoning #

Graham (Quantitative) #

• 4/7 defensive filters passed. Fails: current ratio 1.06 (defense contract prepayments distort — shr-015), P/E 22.7x trailing, P/B 3.30x.
• Growth Stock Addendum applies (shr-004). Forward P/E 17.7x on EUR 16.03 consensus EPS. Implied growth: 4.3%/yr. The 2026 revenue guide implies +14.6% revenue growth. Margin of safety: 32.9% at 7.5% sustained growth on forward EPS.
• Break-even growth: 4.3% on forward earnings — far below the 2026 guidance trajectory.

Klarman (Downside) #

• Falcon recession is the primary bear case. Falcon book-to-bill <1 in FY2025 (31 orders vs 37 deliveries). Backlog 73 units gives ~2 years cover. A demand drop to 25 orders/year would force guidance cut.
• Thales mark-to-market risk. Thales at EUR 222 is near all-time highs. A 20% Thales correction reduces SOTP by EUR 31.80/share.
• Worst realistic case: Both Falcon hits -20% and Thales -20% → stock drops to EUR 215 (-24% from here).

Lynch Classification #

• Slow grower with embedded asset value. Steady defense backlog + cyclical Falcon. Not a fast grower. Returns come from dividend (+42% YoY), buyback (new EUR 3.1B authorization through Nov 2027), and SOTP re-rating.

Insider Signal (shr-002 with shr-035 family discount) #

• Zero independent director open-market purchases in last 30 days. Trappier and Segalen's recent activity (EUR 0 transaction price) is performance-share compensation, not cash buys. Their April 2026 conservation commitments are Art 787B estate planning, not conviction signals.
• Per shr-035, family-control insider signals discount 50%+. Even if family did buy, weighting is low.
• Net signal: AMBER. No bullish insider signal, but no selling either.

Why I'm Buying Today (Before Ex-Div) #

Tomorrow's ex-dividend of EUR 4.78 represents 1.68% of the entry cost. Buying today, holding through ex-date, captures that dividend. After French WHT of 12.8% for non-residents: net dividend = EUR 4.17/share = EUR 4.17 on a 1-share T1 = covers 50%+ of DEGIRO commission. The stock will mechanically drop ~EUR 4.78 on 2026-05-15, so effective post-ex cost basis is EUR 279.02.

The tactical advantage is small (~1.6% of position cost) but real. Not a thesis driver — just a no-cost optimization.

Red Flags #

1. Family control (66.86%) limits independent governance scrutiny. The Dassault family and Airbus together control 77.5% economic / 86.5% voting. Float voting power is only 13.5%. Minority shareholders have minimal leverage on capital allocation decisions.

2. No 10-year EPS continuity proof. Pre-2020 Falcon downturns caused volatility. The screen passes the recent 4-year track record but the longer history has cyclical dips.

3. MRFA India source-code dispute could push the catalyst to 2027-2028. Removes the near-term re-rating event. Doesn't break thesis — backlog covers years.

4. FCAS/SCAF program politics with Germany unresolved. CEO Trappier publicly skeptical of program continuation. Loss of EUR 30-40B future program. But near-term financial impact is neutral (no FCAS revenue in current backlog).

5. Thales correlation is high. AM.PA effectively levers Thales. A Thales-specific event (cyber breach, contract loss, French government policy shift) hits both names simultaneously.

6. Single share price is awkward for incremental sizing. EUR 283.80 means EUR 500 monthly contribution buys 1-2 shares. Compared to AGN.AS at EUR 6 where same budget buys 80+ shares, granularity is limited.

Tranche Plan #

Per shr-034 with multiple AMBER reds active, size T1 smaller (25-30% of planned position).

• T1: 1 share at EUR 283.80 today (before ex-div). Cost ~EUR 285 + EUR 2 fees.
• T2: 1 share at EUR 260-265 (52w low test) OR after MRFA India contract signed.
• T3: 1 share at EUR 240-245 if deep value retest emerges without thesis break.

Total budget if all 3 tranches deploy: ~EUR 850. Captured cleanly within typical satellite monthly contribution rate (3-4 months).

Exit Plan #

No price stops (shr-016). Sell on Graham IV tiered targets:

Fundamental stops: dividend cut → EXIT; Rafale deliveries <25/yr → RE-SCORE; Thales drop >25% → RE-SCORE SOTP.

Bottom Line #

This is the cleanest setup in European defense in May 2026 — not because it's deep value (it isn't) but because 97.8% of the price is covered by net cash and a marketable equity stake. The operating business is being given away for free.

Risk/reward: ~+20% expected over 3 years base case, +48% bull case, -24% bear case. Lower expected value per EUR than the Graham value satellite (AGN.AS +56c/EUR, RI.PA +39c/EUR) but uncorrelated exposure with strong asset coverage.

Recommendation: T1 (1 share) today before ex-dividend. T2 conditional on EUR 260-265 retest or MRFA signing. T3 opportunistic.

Open Questions for Re-Score #

1. Will Falcon orders recover to >40/yr in 2026 H1?
2. Does MRFA India sign in FY2026-27, or slip to 2028?
3. Does the consensus EUR 16 EPS forecast materialize, or does my EUR 14 model prove right (forward P/E 20x — uglier)?
4. Will Thales (HO.PA) hold its current valuation, or correct toward EUR 175-180?